Ticker LaunchCanada to US · Cross-listing · IPA
ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd. (IPA), a British Columbia-based company, cross-listed on Nasdaq on Sep 16, 2020, registering its securities on Form 40FR12B.
ImmunoPrecise Antibodies Ltd. is a technology platform company that supports pharmaceutical and biotechnology partners in discovering and developing therapeutic antibodies against all classes of disease targets. Its shares trade on the TSX Venture Exchange under the symbol IPA.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- IPA
- Listed
- Sep 16, 2020
- Province
- British Columbia
- Registration form
- 40FR12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (40FR12B) Sep 16, 2020
- All filings on EDGAR CIK 1715925
Other Canadian companies listing in the US
- GoldMining Inc.NYSE American · Sep 25, 2020
- Nextech3D.AI Corp.Nasdaq · Sep 15, 2020
- Lightspeed Commerce Inc.NYSE · Sep 9, 2020
- Excellon Resources IncNYSE American · Sep 8, 2020
- Akumin Inc.Nasdaq · Aug 28, 2020
- Medicenna Therapeutics Corp.Nasdaq · Aug 18, 2020